For instance, in pancreatic cancers, epidermal growth factor (EGF) and/or human epidermal receptor-2 (HER-2) mutations are critically responsible for cancer cell proliferation (Oliverira-Cunha et al., 2011). This evidence concerns the gene EGF and familial pancreatic carcinoma.